Dodge & Cox Has Trimmed Thermo Fisher Scientific (TMO) Stake; Innofone Com (INFN) Has 1.2 Sentiment

March 3, 2018 - By Adrian Erickson

Dodge & Cox decreased Thermo Fisher Scientific Inc (TMO) stake by 4.09% reported in 2017Q3 SEC filing. Dodge & Cox sold 1,950 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 8.13%. The Dodge & Cox holds 45,737 shares with $8.65 million value, down from 47,687 last quarter. Thermo Fisher Scientific Inc now has $82.78 billion valuation. The stock increased 0.60% or $1.23 during the last trading session, reaching $206.44. About 1.23M shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since March 3, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Infinera Corporation provides optical transport networking equipment, software, and services worldwide. The company has market cap of $1.56 billion. The companyÂ’s product portfolio consists of Infinera DTN-X Family of terabit-class transport network platforms, including the XTC Series, XTS Series, and XT Series; and Infinera DTN platform that supports various Ethernet and optical transport network client interfaces for long-haul, subsea, and regional mesh networks. It currently has negative earnings. It also provides Infinera XTM Series carrier-grade packet-optical transport platform that enables high-performance metro networks with service-aware, application-specific capabilities; Infinera XTG Series that is a family of passive optical wavelength-division multiplexing products for metro access applications; and Infinera Cloud Xpress Family multiple platforms that are designed to meet the varying needs of cloud service providers, Internet content providers, Internet exchange service providers, enterprises, and other large-scale data center operators.

Since September 5, 2017, it had 0 insider buys, and 7 sales for $20.40 million activity. Herrema Gregory J. also sold $7.32M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares. The insider HORNSTRA PETER E sold $721,091. $9.59 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by CASPER MARC N. Williamson Stephen had sold 5,000 shares worth $1.05M on Wednesday, February 7. 1,000 shares valued at $211,430 were sold by Parrett William G on Friday, February 23. 6,000 shares valued at $1.31M were sold by Durbin Patrick M on Monday, February 5.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 25. They expect $2.40 EPS, up 15.38% or $0.32 from last year’s $2.08 per share. TMO’s profit will be $962.38 million for 21.50 P/E if the $2.40 EPS becomes a reality. After $2.79 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -13.98% negative EPS growth.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 61 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Cleveland given on Friday, September 9. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Monday, October 23 by Robert W. Baird. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Overweight” rating by JP Morgan on Thursday, September 22. As per Tuesday, October 6, the company rating was initiated by Argus Research. The firm earned “Buy” rating on Thursday, January 18 by Robert W. Baird. The company was upgraded on Tuesday, December 8 by Goldman Sachs. The firm has “Hold” rating given on Thursday, March 30 by Jefferies. The rating was reinitiated by Leerink Swann with “Outperform” on Thursday, November 10. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Thursday, February 1 by Jefferies. The company was initiated on Tuesday, September 26 by Goldman Sachs.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.05, from 0.91 in 2017Q2. It improved, as 51 investors sold TMO shares while 383 reduced holdings. 77 funds opened positions while 339 raised stakes. 333.20 million shares or 3.09% more from 323.23 million shares in 2017Q2 were reported. Matrix Asset Advsrs accumulated 2.09% or 67,068 shares. Amica Pension Fund Board Of Trustees has 19,269 shares for 0.44% of their portfolio. Whittier Of Nevada invested in 0.19% or 10,755 shares. Commerce National Bank & Trust reported 219,079 shares stake. Putnam Fl Investment Mgmt holds 0.54% or 29,836 shares. Comerica Securities has 0.16% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 6,035 shares. Millennium Management Ltd Liability Co holds 416,684 shares or 0.12% of its portfolio. 4,920 were accumulated by Mackenzie Financial Corp. Mountain Pacific Invest Advisers Inc Id stated it has 66,405 shares or 1.38% of all its holdings. Madison Holdg reported 24,599 shares stake. Wills Fin owns 1,132 shares. Ontario Teachers Pension Plan Board owns 297,773 shares or 0.75% of their US portfolio. Quadrant Capital Mngmt Ltd Liability Corp, a New Jersey-based fund reported 14,318 shares. Chilton Investment Com Llc has 63,664 shares for 0.47% of their portfolio. Fukoku Mutual Life Insur owns 2,000 shares or 0.06% of their US portfolio.

Dodge & Cox increased Dell Technologies Inc Class V stake by 1.71M shares to 10.03 million valued at $774.75M in 2017Q3. It also upped Glaxosmithkline Plc (NYSE:GSK) stake by 14.83 million shares and now owns 14.86 million shares. Twenty (NASDAQ:FOX) was raised too.

Adirondack Research & Management Inc. holds 1.49% of its portfolio in Infinera Corporation for 431,010 shares. Shannon River Fund Management Llc owns 462,674 shares or 1.34% of their US portfolio. Moreover, Motley Fool Asset Management Llc has 1.18% invested in the company for 661,100 shares. The Colorado-based Elk Creek Partners Llc has invested 1.02% in the stock. Greenbrier Partners Capital Management Llc, a Texas-based fund reported 500,000 shares.

The stock increased 4.00% or $0.4 during the last trading session, reaching $10.41. About 2.42M shares traded or 33.92% up from the average. Infinera Corporation (INFN) has declined 24.42% since March 3, 2017 and is downtrending. It has underperformed by 41.12% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

  • Stratasys Ltd. (SSYS) Reaches $20.34 After 8.00% Up Move; Northwest Natural Gas Co (NWN) Sentiment Is 1.07
  • Nabriva Therapeutics plc (NBRV) Reaches $5.92 After 3.00% Up Move; NEPHROS (NEPH) Shorts Decreased By 1.04%
  • Dodge & Cox Has Trimmed Thermo Fisher Scientific (TMO) Stake; Innofone Com (INFN) Has 1.2 Sentiment
  • Immune Design Corp. (IMDZ) Reaches $3.25 After 6.00% Up Move; 7 Analysts Covering Arena Pharmaceuticals, Inc. (ARNA)
  • Tandem Diabetes Care, Inc. (TNDM) Reaches $3.89 After 5.00% Up Move; NEMETSCHEK AG ORD ORDINARY SHARES (NEMTF) SI Increased By 4%
  • Oz Management LP Decreased Facebook (Call) (FB) Position By $66.76 Million; Group 1 Automotive (GPI)’s Sentiment Is 0.99
  • Swift Run Capital Management Trimmed Its Huntsman (HUN) Position as Shares Rose; Exxon Mobil (XOM) Holder Menora Mivtachim Holdings LTD Cut Its Holding
  • COBRASMA SA (CBMA4) Is Yet to See Trading Action on Mar 3
  • Ascendis Pharma A/S (ASND) Touches $65.99 High on Mar, 3; PS Business Parks (PSB) Has 1.39 Sentiment
  • On March 2-3 The Blockchain – based LATOKEN (LA) decreases in value over -4.80%